GrantWise
HORIZON EUROPE TOPIC · Cluster 1 · Health

Tools and technologies to support health adaptation to climate change

HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03 — the expected outcomes as checkable statements, what evaluators look for in this topic, and the conditions that shape the proposal.

ForthcomingPCPDeadline 17 February 2027EUR 4 million to EUR 5 million per project

GrantWise › Horizon Europe topics › HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03

TopicHORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03
StatusForthcoming
CallHORIZON-HLTH-2027-01 — Cluster 1 - Health (Single stage - 2027/1)
DestinationLiving and working in a health-promoting environment (2026-27)
Type of actionPre-commercial Procurement
Opening29 October 2026
Deadline17 February 2027
BudgetEUR 4 million to EUR 5 million per project · 4 projects expected · EUR 20 million in total
TemplateWork Programme 2026–2027 application form

Expected outcomes

The topic does not say whether all outcomes must be addressed; treat them all as relevant. The topic says: “This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Living and working in a health-promoting environment” and the EU Mission on Adaptation to Climate Change. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to most of the following expected…”

  1. EO1 Populations, public authorities and healthcare systems benefit from innovative solutions and technologies to increase surveillance and prevention and reduce climatic and environmental health risks.
  2. EO2 Policymakers and public authorities develop and implement environment, climate change and health policies and interventions supported by nearly fit-for-use solutions that can be further upscaled and deployed.

Expected impacts named in the destination

The wider, long-term effects the destination seeks. Your outcomes feed them; they are not project deliverables.

  1. EI1 Policymakers and regulators are aware and well informed about climatic, environmental, socio-economic and occupational risk factors as well as health-promoting factors across society.
  2. EI2 Climatic, environmental, occupational, social, economic, and health policies and practices at the EU, national and regional level are sustainable and based on solid scientific evidence.
  3. EI3 The upstream determinants of health are known, understood and reduced.
  4. EI4 The health threats and burden and patient safety burdens resulting from exposure to climate drivers are lessened, so that the related number of deaths and illnesses is substantially reduced.
  5. EI5 Living and working environments in European cities and regions are healthier, more inclusive, safer, resilient and sustainable.
  6. EI6 The healthcare sector reduces its environmental footprint and transitions towards carbon neutrality.
  7. EI7 The adaptive capacity and resilience of populations and health systems in the EU to climate and environmental change-related to mental and physical health risks are strengthened.
  8. EI8 Citizens’ health and wellbeing are protected and promoted, and premature deaths, diseases and inequalities related to climate related risks are prevented.
  9. EI9 Citizens understand better complex climate, environment and health issues, and effective measures to address them and support related policies and regulations.

What evaluators will look for in this topic

Expected outcomes

  • The topic does not say whether all outcomes must be addressed; treat them all as relevant.
  • For each outcome (EO1 to EO2), name who will use or adopt your results (a specific group, not “industry” or “society”), how they get them, and the indicator that shows the change, with baseline, target and date.
  • Use the topic's own words for each outcome, so the evaluator can tick it off.

What the scope asks for

Evaluators check the proposal against these sentences of the scope. Answer each one visibly, in the call's own words.

  • “Proposals under this topic are expected to close this gap and build on innovations being developed in the field, supported through, among others, EU Research and Innovation (R&I) funding.”
  • “Proposals under this topic should support the development of innovative solutions, tools and models to enhance surveillance, prediction, prevention, risk management and diagnosis (e.g. testing), supporting the adaptation, resilience, and preparedness of healthcare systems and populations to climatic and climate-related environmental health risks.”
  • “Proposals are encouraged to consider, where relevant, the data, expertise and services offered by European research infrastructures in the environment, climate and health domain.”
  • “Continuous dialogue between demand and supply side is required for the success of PCPs, therefore the effective involvement of end users should be considered in the proposal.”
  • “Therefore, procurers should declare in the proposal their interest to purchase at least one solution resulting from the PCP in case the PCP delivers successful solutions and indicate whether they will i) procure the solution(s) as part of the PCP or ii) in a separate follow-up procurement after the PCP.”
  • “In the second case, the procurers should include in the proposal a deliverable that prepares the follow-up procurement to purchase successful solution(s) after the PCP.”
  • “Projects are encouraged to channel their activities through the Mission Implementation Platform and the Mission’s Community of Practice.”
  • “For digital technologies concerned, appropriate measures for the security of the communications between the intended parties should be considered, in particular based on the use of post-quantum cryptography.”

Conditions that shape the proposal

  • Other Eligibility Conditions: “In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.”
  • Other Eligibility Conditions: “The specific conditions for actions with PCP/PPI procurements in section H of the General Annexes apply to grants funded under this topic.”
  • Legal and financial set-up of the grants: “Beneficiaries must ensure that the subcontracted work is performed in the EU and Associated Countries - unless otherwise approved by the granting authority.”
  • Legal and financial set-up of the grants: “Grants award under this topic will have to submit the following deliverable: To stimulate dialogue with the supply side, procurers are required to organise an open market consultation before launching the procurement and deliver a report on the outcomes of this consultation.”
  • Legal and financial set-up of the grants: “Beneficiaries will be subject to the following additional dissemination obligations: Procurers are required to promote the call for tenders widely across the EU and Associated Countries to potentially interested suppliers.”
  • Legal and financial set-up of the grants: “Beneficiaries may provide financial support to third parties to ensure the deployment and impact of the project outcomes. The support to third parties can only be provided in the form of grants. The maximum amount to be granted to each third party is EUR 60 000.”

Impact pathway and traps

  • Users or citizens are part of the scope. Show how they take part in the design and testing, not only that they are informed.
  • Keep outputs, outcomes and impacts apart: what you deliver, what changes when others use it, and the long-term effect.
  • For each destination impact you claim, show which of your outcomes feeds it. Destination impacts are long-term effects, not project deliverables.
  • Name the barriers outside the project (regulation, markets, user behaviour) that could block uptake, and what you will do if they do.
  • Section 2.3 (the summary canvas) is optional on this call; the old split into scientific, economic and societal impact is no longer required.
The scope, as published

Enhancing the adaptive capacity and resilience of healthcare systems and communities is crucial to prevent and reduce the health impacts of climate change. However, many of the urgently needed technologies, tools, systems and solutions are still at an early developmental stage, relying on further support for development and testing. Proposals under this topic are expected to close this gap and build on innovations being developed in the field, supported through, among others, EU Research and Innovation (R&I) funding. In this context, Pre-commercial Procurement (PCP) projects can drive innovation and speed up the development of technologies for health adaptation to climate change by supporting the research and development of solutions to increase the resilience and preparedness of healthcare systems, communities and individuals against climate change. By focusing on early-stage solutions, PCP fosters collaboration between public sector buyers (e.g. public authorities, local authorities, health organisations) and private developers to create climate adaptation technologies, systems and solutions in the context of human health. These solutions will accelerate the transition to more climate-resilient healthcare systems and societies. PCP actions target consortia of procurers with similar needs that want to jointly procure the development of innovative solutions for supporting adaptation efforts. This topic does not provide direct funding to developers, industry or research organisations to perform Research and Development (R&D). They will be able to respond to the call for tenders launched by consortia of procurers funded under this topic. Proposals under this topic should support the development of innovative solutions, tools and models to enhance surveillance, prediction, prevention, risk management and diagnosis (e.g. testing), supporting the adaptation, resilience, and preparedness of healthcare systems and populations to climatic and climate-related environmental health risks. More specifically proposals can support any of the areas listed below: Geospatial technologies and decision-support frameworks that help local authorities and healthcare providers track at “high resolution” and better manage direct and indirect health risks related to climate change. Real-time risk surveillance and early-warning technologies and monitoring tools that provide critical information for timely decision-making and responses related to the health risks of climate change. Technologies and solutions that facilitate the transition to climate-resilient healthcare facilities and services. Activities targeting the general infrastructure (e.g. ventilation, construction or refurbishment) are out of scope. Technologies, tools, procedures and solutions for health risk management, prevention and resilience, enhancing strategies and interventions for health adaptation to climate change in communities and occupational settings. Innovative tools reducing risk and exposure to climate related environmental factors that exacerbate health risks. This topic considers tools and technologies that could be developed and tested to support adaptation at both the community and healthcare system levels. This approach would comprehensively address the needs of health authorities and those of local authorities and public organisations involved in risk management. Consortium composition could include diverse stakeholders such as hospitals, primary healthcare providers, domestic care services, municipalities, civil protection entities and government agencies. The focus can extend beyond climate variables to include other related environmental and ecological factors (for example air pollution) that interact with climate change and impact public health. Proposals are encouraged to consider, where relevant, the data, expertise and services offered by European research infrastructures in the environment, climate and health domain. Continuous dialogue between demand and supply side is required for the success of PCPs, therefore the effective involvement of end users should be considered in the proposal. Involvement of procurement decision makers is needed to ensure that end solution(s) are adopted by healthcare systems and/or local authorities and public organisations increasing the societal impact of the related research activities. Therefore, procurers should declare in the proposal their interest to purchase at least one solution resulting from the PCP in case the PCP delivers successful solutions and indicate whether they will i) procure the solution(s) as part of the PCP or ii) in a separate follow-up procurement after the PCP. In the first case, procurers can implement the project as a fast-track PCP (see section H of the General Annexes of this Work Programme for further details) and foresee the budget to purchase at least one solution during the PCP. In the second case, the procurers should include in the proposal a deliverable that prepares the follow-up procurement to purchase successful solution(s) after the PCP. This topic is co-financed by the EU Mission on Adaptation to climate change and supports the follow up to the 2023 Communication on the Missions. Projects are encouraged to channel their activities through the Mission Implementation Platform and the Mission’s Community of Practice. For digital technologies concerned, appropriate measures for the security of the communications between the intended parties should be considered, in particular based on the use of post-quantum cryptography. The catalogue of European Strategy Forum on Research Infrastructures (ESFRI) research infrastructures portfolio can be browsed on the ESFRI website: https://ri-portfolio.esfri.eu https://research-and-innovation.ec.europa.eu/funding/funding-opportunities/funding-programmes-and-open-calls/horizon-europe/eu-missions-horizon-europe/adaptation-climate-change_en…

Other topics in HORIZON-HLTH-2027-01

Source and attribution

Topic text from the official topic page on the EU Funding & Tenders Portal, retrieved 19 October 2026. © European Union, reused under Commission Decision 2011/833/EU (CC BY 4.0). Changes: the expected outcomes and impacts are split into numbered statements, long passages are shortened, and the evaluator checklist is GrantWise's own commentary. Your call and the Work Programme always win; check them before you submit. GrantWise is independent and not affiliated with, endorsed by, or acting on behalf of the European Commission.